Literature DB >> 29863072

Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.

Takuma Yamashita1, Yuki Takahashi1, Yoshinobu Takakura1.   

Abstract

Exosomes are cell-derived vesicles with a diameter 30-120 nm. Exosomes contain endogenous proteins and nucleic acids; delivery of these molecules to exosome-recipient cells causes biological effects. Exosomes derived from some types of cells such as mesenchymal stem cells and dendritic cells have therapeutic potential and may be biocompatible and efficient agents against various disorders such as organ injury. However, there are many challenges for the development of exosome-based therapeutics. In particular, producing exosomal formulations is the major barrier for therapeutic application because of their heterogeneity and low productivity. Development and optimization of producing methods, including methods for isolation and storage of exosome formulations, are required for realizing exosome-based therapeutics. In addition, improvement of therapeutic potential and delivery efficiency of exosomes are important for their therapeutic application. In this review, we summarize current knowledge about therapeutic application of exosomes and discuss some challenges in their successful use.

Entities:  

Keywords:  exosome; production; therapeutic application

Mesh:

Year:  2018        PMID: 29863072     DOI: 10.1248/bpb.b18-00133

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  69 in total

1.  Protective effects of bovine milk exosomes against oxidative stress in IEC-6 cells.

Authors:  Lanfang Wang; Zhexi Shi; Xinyan Wang; Shu Mu; Xiaoyan Xu; Li Shen; Ping Li
Journal:  Eur J Nutr       Date:  2020-04-23       Impact factor: 5.614

Review 2.  Role of miRNAs in immune responses and immunotherapy in cancer.

Authors:  Maria Angelica Cortez; Simone Anfossi; Rishab Ramapriyan; Hari Menon; Semra Cemre Atalar; Maureen Aliru; James Welsh; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2019-04       Impact factor: 5.006

Review 3.  Exosomes: cell-created drug delivery systems.

Authors:  Anastasia Familtseva; Nevena Jeremic; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2019-05-09       Impact factor: 3.396

4.  Extracellular Vesicle Therapeutics in Regenerative Medicine.

Authors:  Aya Imafuku; Sebastian Sjoqvist
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Extracellular Vesicles Mediate Neuroprotection and Functional Recovery after Traumatic Brain Injury.

Authors:  Min Kyoung Sun; Austin P Passaro; Charles-Francois Latchoumane; Samantha E Spellicy; Michael Bowler; Morgan Goeden; William J Martin; Philip V Holmes; Steven L Stice; Lohitash Karumbaiah
Journal:  J Neurotrauma       Date:  2020-02-10       Impact factor: 5.269

Review 6.  Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.

Authors:  Bruna Corradetti; Simone Pisano; Robert Steven Conlan; Mauro Ferrari
Journal:  J Pharmacol Exp Ther       Date:  2019-02-08       Impact factor: 4.030

7.  Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors.

Authors:  Bryant C Nelson; Samantha Maragh; Ionita C Ghiran; Jennifer C Jones; Paul C DeRose; Elzafir Elsheikh; Wyatt N Vreeland; Lili Wang
Journal:  Nanomedicine (Lond)       Date:  2020-09-04       Impact factor: 5.307

Review 8.  Exosomes in osteosarcoma research and preclinical practice.

Authors:  Xiao-Bo Zhang; Rui-Hao Zhang; Xin Su; Jin Qi; Yi-Cun Hu; Jin-Tao Shi; Kai Zhang; Ke-Ping Wang; Hai-Yu Zhou
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

9.  Biomimetic nanovesicle design for cardiac tissue repair.

Authors:  Sruti Bheri; Jessica R Hoffman; Hyun-Ji Park; Michael E Davis
Journal:  Nanomedicine (Lond)       Date:  2020-08-05       Impact factor: 5.307

10.  Exosome and Biomimetic Nanoparticle Therapies for Cardiac Regenerative Medicine.

Authors:  Sydney J Stine; Kristen D Popowski; Teng Su; Ke Cheng
Journal:  Curr Stem Cell Res Ther       Date:  2020       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.